Summit Insights downgrades Silicon Labs to Hold with recovery seen priced in

As previously reported, Summit Insights downgraded Silicon Labs to Hold from Buy. While stating that Silicon Labs’ March quarter results and June quarter outlook “clearly support our view of a recovery from the industry downturn and inventory correction after an extended period of customers’ double ordering,” the firm also believes a recovery is now priced into the share price and expects the stock to be an inline performer.